Accès ouvert
2022
article
OpenAlex
Timothy Hahn, Carrie Daymont, Timothy Beukelman, Brandt Groh et autres
BACKGROUND: Children with juvenile idiopathic arthritis (JIA) who achieve a drug free remission often experience a flare of their disease requiring either intraarticular steroids (IAS) or systemic treatment with disease modifying anti-rheumatic drugs (DMARDs). IAS offer an opportunity to recapture disease control …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Timothy Beukelman, Aimee Lougee, Roland Matsouaka, David H. Collier et autres
BACKGROUND: We aimed to characterize etanercept (ETN) use in juvenile idiopathic arthritis (JIA) patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. METHODS: The CARRA Registry is a convenience cohort of patients with paediatric onset rheumatic diseases, including JIA. …
us, ca
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Nayimisha Balmuri, William Daniel Soulsby, Victoria Cooley, Linda M. Gerber et autres
BACKGROUND: The impact of social determinants of health on children with polyarticular juvenile idiopathic arthritis (pJIA) is poorly understood. Prompt initiation of treatment for pJIA is important to prevent disease morbidity; however, a potential barrier to early treatment of pJIAs is delayed …
us
(code pays fourni par la source)